Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 39,224 | 39,967 | 36,013 | 38,810 | 58,357 |
| Cost of Goods | 29,166 | 29,963 | 30,075 | 27,528 | 48,786 |
| Gross Profit | 10,058 | 10,004 | 5,938 | 11,282 | 9,571 |
| Operating Expenses | 163,252 | 75,044 | 181,859 | 93,172 | 97,905 |
| Operating Income | -153,028 | -64,077 | -175,846 | -81,362 | -87,548 |
| Interest Expense | 2,757 | 3,538 | 3,542 | 3,575 | 3,571 |
| Other Income | 158,472 | 6,890 | 6,069 | 6,759 | 8,383 |
| Pre-tax Income | 2,687 | -60,725 | -173,319 | -78,178 | -82,736 |
| Income Tax | N/A | N/A | N/A | N/A | -718 |
| Net Income Continuous | 2,371 | -60,725 | -173,319 | -78,178 | -82,018 |
| Net Income | $2,371 | $-60,725 | $-173,319 | $-78,178 | $-82,018 |
| EPS Basic Total Ops | 0.02 | -0.22 | -0.64 | -0.29 | -0.31 |
| EPS Basic Continuous Ops | 0.02 | -0.22 | -0.64 | -0.29 | -0.30 |
| EPS Diluted Total Ops | -0.44 | -0.22 | -0.64 | -0.29 | -0.31 |
| EPS Diluted Continuous Ops | 0.07 | -0.22 | -0.64 | -0.29 | -0.30 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.17 | -0.20 | N/A | N/A |
| EBITDA(a) | $-53,160 | $-51,069 | $-71,898 | $-73,379 | $-78,601 |